Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) on January 31 and set a price target of $515.00. The company’s shares closed last ...

In a report released on January 31, Jesalyn Wong from Evercore ISI maintained a Buy rating on Deckers Outdoor (DECK – Research Report), with a price target of $235.00. The company’s shares ...

Investment banking firm Evercore has issued its January report, highlighting the market performances of several U.S. defense and government services companies. The premier source of breaking ...

Evercore ISI cut its rating on Kraft Heinz (NASDAQ:KHC) stock from Outperform to In-Line and reduced the price target to $35 from the previous $38. The investment bank cited several reasons for ...

We recently published a list of Top 10 AI News You Shouldn’t Miss. In this article, we are going to take a look at where Salesforce, Inc. (NYSE:CRM) stands against other top AI news you shouldn ...

Fintel reports that on January 31, 2025, Evercore ISI Group initiated coverage of NNN REIT (NYSE:NNN) with a In-Line recommendation. As of January 28, 2025, the average one-year price target for ...

We recently published a list of Top 10 Trending AI News and Ratings. In this article, we are going to take a look at where NRG Energy, Inc. (NYSE:NRG) stands against other top trending AI news and ...

Evercore (EVR) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...

Evercore ISI analysts recently updated their “AI Enablers, Adopters, and Adapters” stock list. Salesforce, Inc. (NYSE:CRM) was part of the list. These stocks, selected from the Russell 3000 ...

On Wednesday, Evercore ISI analyst upgraded Aon Corp (NYSE:AON) stock from In Line to Outperform, raising the price target to $420 from $407. The upgrade reflects the analyst's optimism about the ...

Fintel reports that on January 15, 2025, Evercore ISI Group downgraded their outlook for Schlumberger (NYSE:SLB) from Outperform to In-Line. Analyst Price Forecast Suggests 38.91% Upside As of ...

https://www.tipranks.com/news/the-fly/warby-parker-price-target-raised-to-23-from-17-at-morgan-stanley Evercore ISI raised the firm’s price target on BioCryst (BCRX ...